Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kalceks is a prominent Latvian pharmaceutical company that specializes in the development, manufacturing, and distribution of generic medicines, with a primary focus on the hospital and intensive care segments. As a key subsidiary of the Grindeks Group, the company excels in producing high-quality injectable formulations for therapeutic areas including the central nervous system, cardiovascular health, and pain management. Founded in 1920, it is one of the oldest pharmaceutical enterprises in the Baltic States and maintains a strong global footprint, exporting products to more than 50 countries. The company's portfolio features a wide range of essential medications such as analgesics, anesthetics, and neuromuscular blockers. Kalceks operates in strict adherence to international Good Manufacturing Practice (GMP) standards, ensuring the safety and efficacy of its diverse product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kalcex.